Dr. Lugo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 10th Ave
New York, NY 10019Phone+1 212-523-6500Fax+1 212-523-7182
Summary
- Dr. Luz Lugo is a New York-based physician specializing in Infectious Disease. She received her medical education from Ponce Health Sciences University School of Medicine before completing her Residency and Fellowship in Internal Medicine and Infectious Disease at Mount Sinai Hospital. Currently, she serves as the Medical Director of Samuels Clinic at Mount Sinai West. Dr. Lugo has several publications pertaining to infectious disease in renowned journals, with a significant focus on Mpox disease and SARS-CoV-2 seroconversion. She has been honored with CMS Meaningful Use Stage 1 Certification from Epic Systems Corporation and recognitions from the National Committee for Quality Assurance, reflecting her commitment to quality care.
Education & Training
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Infectious Disease, 1999 - 2001
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1996 - 1999
- Ponce Health Sciences University School of MedicineClass of 1996
Certifications & Licensure
- NY State Medical License 1999 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2012-2015
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2012-2015
Publications & Presentations
PubMed
- 31 citationsMpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study.Hallie Cohn, Nathaniel Bloom, Gianna Y Cai, Jordan J Clark, Alison Tarke
The Lancet. Infectious Diseases. 2023-11-01 - Clinical Characteristics and Outcomes of Patients With Mpox Who Received Tecovirimat in a New York City Health System.Christopher Vo, Rustin Zomorodi, Richard Silvera, Logan Bartram, Luz Amarilis Lugo
Open Forum Infectious Diseases. 2023-11-01 - 22 citationsEvaluation and validation of an RT-PCR assay for specific detection of monkeypox virus (MPXV).Alberto Paniz-Mondolfi, Susana Guerra, Marina Muñoz, Nicolas Luna, Matthew M Hernandez
Journal of Medical Virology. 2023-01-01
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: